Robert W. Baird Lowers Envista (NYSE:NVST) Price Target to $19.00

Envista (NYSE:NVST) had its price target cut by Robert W. Baird from $22.00 to $19.00 in a research note published on Thursday, Benzinga reports. They currently have a neutral rating on the stock.

NVST has been the subject of several other reports. TheStreet lowered Envista from a c rating to a d+ rating in a research report on Wednesday, February 7th. Jefferies Financial Group downgraded Envista from a buy rating to a hold rating and cut their price objective for the stock from $30.00 to $23.00 in a research report on Friday, February 9th. Leerink Partnrs reaffirmed an underperform rating on shares of Envista in a research report on Monday, February 26th. UBS Group initiated coverage on shares of Envista in a research report on Friday, January 5th. They set a neutral rating and a $26.00 price target for the company. Finally, SVB Leerink initiated coverage on shares of Envista in a report on Monday, February 26th. They issued an underperform rating and a $19.00 price objective on the stock. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of Hold and an average price target of $25.86.

Envista Trading Down 4.1 %

NYSE NVST opened at $19.00 on Thursday. The business’s fifty day simple moving average is $20.66 and its 200-day simple moving average is $22.50. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.34. Envista has a 52 week low of $18.09 and a 52 week high of $36.74.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, May 1st. The company reported $0.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.31 by ($0.05). Envista had a positive return on equity of 5.84% and a negative net margin of 4.70%. The firm had revenue of $623.60 million for the quarter, compared to analyst estimates of $634.85 million. During the same quarter in the previous year, the business posted $0.38 earnings per share. Envista’s revenue for the quarter was down .6% on a year-over-year basis. On average, equities research analysts predict that Envista will post 1.26 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Headinvest LLC acquired a new stake in shares of Envista in the 3rd quarter valued at $28,000. Fifth Third Bancorp raised its stake in Envista by 98.1% in the fourth quarter. Fifth Third Bancorp now owns 1,254 shares of the company’s stock valued at $30,000 after buying an additional 621 shares in the last quarter. Itau Unibanco Holding S.A. purchased a new stake in Envista during the 3rd quarter worth about $47,000. Covestor Ltd lifted its holdings in Envista by 33.9% during the 3rd quarter. Covestor Ltd now owns 2,462 shares of the company’s stock worth $69,000 after buying an additional 624 shares during the last quarter. Finally, Signaturefd LLC boosted its position in shares of Envista by 1,297.9% during the 4th quarter. Signaturefd LLC now owns 2,614 shares of the company’s stock worth $63,000 after acquiring an additional 2,427 shares in the last quarter.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.